1.
Long-Term Efficacy of Abrocitinib in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE EXTEND. J of Skin [Internet]. 2024 Jan. 16 [cited 2025 Apr. 18];8(1):s329. Available from: https://skin.dermsquared.com/skin/article/view/2462